Submitted by Anonymous (not verified) on 23 May 2025 - 7:44
Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised